Top compounds associated with response to TTLL10


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.085 0.01
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA pluripotin CTRPv2 pan-cancer AAC -0.086 0.02
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.084 0.02
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.09 0.02
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.08 0.02
Download CSV